Chemoinformaics analysis of N-Methylholarrhimine
| Molecular Weight | 101.149 | nRot | 0 |
| Heavy Atom Molecular Weight | 90.061 | nRig | 6 |
| Exact Molecular Weight | 101.084 | nRing | 1 |
| Solubility: LogS | 0.968 | nHRing | 1 |
| Solubility: LogP | -0.147 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 17.5867 |
| nHD | 0 | BPOL | 14.4813 |
| QED | 0.424 |
| Synth | 2.053 |
| Natural Product Likeliness | -1.353 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.003 |
| CACO-2 | -4.388 |
| MDCK | 0.0000101 |
| BBB | 0.962 |
| PPB | 0.0979029 |
| VDSS | 1.178 |
| FU | 0.899696 |
| CYP1A2-inh | 0.031 |
| CYP1A2-sub | 0.216 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.934 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.259 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.87 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.202 |
| CL | 7.833 |
| T12 | 0.512 |
| hERG | 0.031 |
| Ames | 0.075 |
| ROA | 0.403 |
| SkinSen | 0.836 |
| Carcinogencity | 0.893 |
| EI | 0.934 |
| Respiratory | 0.829 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.936229 |